5-Fluorouracil response in a large panel of colorectal cancer cell lines is associated with mismatch repair deficiency
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Colorectal cancer is (CRC) one of the commonest cancers and its therapy is still based on few drugs. Currently, no biological criteria are used to choose the most effective of the established drugs for treatment. METHODS: A panel of 77 CRC cell lines was tested for sensitivity to 5-fluorouracil (5FU) using the SRB assay. The responses were grouped into three categories and correlated with genetic changes in the cell lines. RESULTS: The strongest and most clearcut correlation was between 5-fluorouracil response and replication error status (mismatch repair deficiency). All the other significant correlations (loss of heterozygosity for DCC and mutations in TGFbIIR) are secondary to the association with replication error status. INTERPRETATION AND CONCLUSION: Our findings validate previous analyses based mainly on clinical data, and indicate that replication error status could be a useful guide to 5-fluorouracil-based CRC therapy. Essentially, all previously described correlations with 5FU response are secondary to the association with replication error status.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
5-Fluorouracil: mechanisms of action and clinical strategies
Longley, D. B., Harkin, D. P., & Johnston, P. G. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1074 · Cited by 5,332 · cited 2×
“…that, after conversion into its main active metabolites (FdÌMP, FdUTP, and FUTP), induces, among other effects, RNA and DNA damage through incorporation of its metabolites into nucleic acids, and inhibition of thymidylate synthase (TS) and therefore DNA synthesis (Longley et al, 2003).”
BackgroundRibic, C. M., Sargent, D. J., Moore, M. J., Thibodeau, S. N., French, A. J., Goldberg, R. M., Hamilton, S. R., Laurent-Puig, P., Gryfe, R., Shepherd, L. E., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022289 · Cited by 2,160 · cited 4×
“These results are in agreement with the clinical data for the adjuvant setting (Ribic et al, 2003; Warusavitarne and Schnitzler, 2007; Muller et al, 2008), and hence support the use of a panel of cell lines for preclinical testing of associations of drug responses with genetic changes in cancers.”
BackgroundResultInfluentialLinardou, H., Dahabreh, I. J., Kanaloupiti, D., Siannis, F., Bafaloukos, D., Kosmidis, P., Papadimitriou, C. A., & Murray, S. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70206-7 · Cited by 739 · cited 1×
“KRAS activating mutations have recently emerged as predictive biomarkers for treatment of CRC with EGFR inhibiting agents in clinical trials (Linardou et al, 2008; Riely and Ladanyi, 2008).”
BackgroundArnold, C. N., Goel, A., & Boland, C. R. (2003) · International Journal of Cancer · doi:10.1002/ijc.11176 · Cited by 280
Analysis of P53 mutations and their expression in 56 colorectal cancer cell lines
Liu, Y., & Bodmer, W. F. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510146103 · Cited by 257
Self-citation
Cited by
CMScaller: an R package for consensus molecular subtyping of colorectal cancer pre-clinical models
Eide, P. W., Bruun, J., Lothe, R. A., & Sveen, A. (2017) · Scientific Reports · doi:10.1038/s41598-017-16747-x · Cited by 437
Cancer Cell Lines for Drug Discovery and Development
Wilding, J. L., & Bodmer, W. F. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-2971 · Cited by 432
“Using this colorectal cancer cell line panel, we have shown a clear relationship between 5-fluorouracil sensitivity and mismatch repair status in a subset of 77 cell lines using a relatively high-throughput test procedure and an objective categorization of response (15).”
BackgroundMethodSelf-citationMouradov, D., Sloggett, C., Jorissen, R. N., Love, C. G., Li, S., Burgess, A. W., Arango, D., Strausberg, R. L., Buchanan, D., Wormald, S., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-0013 · Cited by 375
Self-citationGornowicz, A., Szymanowska, A., Mojzych, M., Bielawski, K., & Bielawska, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21155221 · Cited by 298
Yamaguchi, N., Weinberg, E. M., Nguyen, A., Liberti, M. V., Goodarzi, H., Janjigian, Y. Y., Paty, P. B., Saltz, L. B., Kingham, T. P., Loo, J. M., et al. (2019) · eLife · doi:10.7554/elife.52135 · Cited by 91
Metadata
- Authors
- Bracht, K., Nicholls, A. M., Liu, Y., & Bodmer, W. F.
- Venue
- British Journal of Cancer
- Published
- 2010-07
- Volume
- 103
- Issue
- 3
- Pages
- 340-346
- ISSN
- 0007-0920 (ISSN-L)
- 1532-1827
- OpenAlex
- W1987145875
- Cited by
- 110
- References
- 5
- FWCI
- 1.73
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.